Search research articles
Contact Us
Filters
Showing results (31-40 of 295) with videos related to
Page
of 30
Sort By:
The New England Journal of Medicine
|
January 1, 2015
Inhaled glucocorticoids and COPD exacerbations
Christopher E Brightling, Ian D Pavord, Mona Bafadhel
The Journal of Allergy and Clinical Immunology
|
October 15, 2014
D prostanoid receptor 2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells
Sally E Stinson, Yassine Amrani, Christopher E Brightling
The European Respiratory Journal
|
February 13, 2025
Reply to: Response and remission in asthma with tezepelumab: overlapping concepts informing on type-2 inflammatory-dependent treatment effects
Neil Martin, Michael E Wechsler, Christopher E Brightling, et al.
Lung
|
December 17, 2013
Cough in asthma is due to eosinophilic airway inflammation: a pro/con debate
Akio Niimi, Christopher E Brightling, Peter V Dicpinigaitis
The European Respiratory Journal
|
December 14, 2019
Fatty airways: a source of good and bad fats?
Christopher E Brightling, Andrew B Tobin, Graeme Milligan
The Journal of Allergy and Clinical Immunology. in Practice
|
July 8, 2019
Cough and Eosinophilia
Sarah Diver, Richard J Russell, Christopher E Brightling
Treatments in Respiratory Medicine
|
September 3, 2005
Biomarkers predicting response to corticosteroid therapy in asthma
Christopher E Brightling, Ruth H Green, Ian D Pavord
British Medical Bulletin
|
March 11, 2021
The different phenotypes of COPD
Ahmed Yousuf, Hamish McAuley, Omer Elneima, et al.
Current Opinion in Pulmonary Medicine
|
November 25, 2011
Computed tomography scans in severe asthma: utility and clinical implications
Carolina Walker, Sumit Gupta, Ruth Hartley, et al.
The European Respiratory Journal
|
January 18, 2020
Clinical utility of fractional exhaled nitric oxide in severe asthma management
Andrew Menzies-Gow, Adel H Mansur, Christopher E Brightling
Page
of 30
Search research articles
Search
Showing results (31-40 of 295) with videos related to
Sort By:
Page
of 30
The New England Journal of Medicine
|
January 1, 2015
Inhaled glucocorticoids and COPD exacerbations
Christopher E Brightling, Ian D Pavord, Mona Bafadhel
The Journal of Allergy and Clinical Immunology
|
October 15, 2014
D prostanoid receptor 2 (chemoattractant receptor-homologous molecule expressed on TH2 cells) protein expression in asthmatic patients and its effects on bronchial epithelial cells
Sally E Stinson, Yassine Amrani, Christopher E Brightling
The European Respiratory Journal
|
February 13, 2025
Reply to: Response and remission in asthma with tezepelumab: overlapping concepts informing on type-2 inflammatory-dependent treatment effects
Neil Martin, Michael E Wechsler, Christopher E Brightling, et al.
Lung
|
December 17, 2013
Cough in asthma is due to eosinophilic airway inflammation: a pro/con debate
Akio Niimi, Christopher E Brightling, Peter V Dicpinigaitis
The European Respiratory Journal
|
December 14, 2019
Fatty airways: a source of good and bad fats?
Christopher E Brightling, Andrew B Tobin, Graeme Milligan
The Journal of Allergy and Clinical Immunology. in Practice
|
July 8, 2019
Cough and Eosinophilia
Sarah Diver, Richard J Russell, Christopher E Brightling
Treatments in Respiratory Medicine
|
September 3, 2005
Biomarkers predicting response to corticosteroid therapy in asthma
Christopher E Brightling, Ruth H Green, Ian D Pavord
British Medical Bulletin
|
March 11, 2021
The different phenotypes of COPD
Ahmed Yousuf, Hamish McAuley, Omer Elneima, et al.
Current Opinion in Pulmonary Medicine
|
November 25, 2011
Computed tomography scans in severe asthma: utility and clinical implications
Carolina Walker, Sumit Gupta, Ruth Hartley, et al.
The European Respiratory Journal
|
January 18, 2020
Clinical utility of fractional exhaled nitric oxide in severe asthma management
Andrew Menzies-Gow, Adel H Mansur, Christopher E Brightling
Page
of 30